Literature DB >> 14676200

Phosphorylation of conserved casein kinase sites regulates cAMP-response element-binding protein DNA binding in Drosophila.

Junjiro Horiuchi1, Wei Jiang, Hong Zhou, Priscilla Wu, Jerry C P Yin.   

Abstract

The Drosophila homolog of cAMP-response element-binding protein (CREB), dCREB2, exists with serine 231, equivalent to mammalian serine 133, in a predominantly phosphorylated state. Thus, unlike the mammalian protein, the primary regulation of dCREB2 may occur at a different step from serine 231 phosphorylation. Although bacterially expressed dCREB2 bound cAMP-response element sites, protein from Drosophila extracts was unable to do so unless treated with phosphatase. Phosphorylation of recombinant protein by casein kinase (CK) I or II, but not calcium-calmodulin kinase II or protein kinase A, inhibited DNA binding. Up to four conserved CK sites likely to be phosphorylated in vivo were responsible for this effect, and these sites were phosphorylated by a kinase present in Drosophila cell extracts that biochemically resembles CKII. We propose that the relative importance of different signaling pathways in regulating CREB activity may differ between Drosophila and mammals. In Drosophila, the dephosphorylation of CK sites appears to be the major regulatory step, while phosphorylation of serine 231 is necessary but secondary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14676200     DOI: 10.1074/jbc.M212839200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Structural Basis for Graded Inhibition of CREB:DNA Interactions by Multisite Phosphorylation.

Authors:  Sergey Shnitkind; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2018-12-13       Impact factor: 3.162

Review 2.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

3.  cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila.

Authors:  Kanae Iijima-Ando; Priscilla Wu; Eric A Drier; Koichi Iijima; Jerry C P Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

4.  Recurrent Circuitry Sustains Drosophila Courtship Drive While Priming Itself for Satiety.

Authors:  Stephen X Zhang; Dragana Rogulja; Michael A Crickmore
Journal:  Curr Biol       Date:  2019-08-29       Impact factor: 10.834

5.  Nuclear gating of a Drosophila dCREB2 activator is involved in memory formation.

Authors:  Robin Fropf; Thomas C Tubon; Jerry C P Yin
Journal:  Neurobiol Learn Mem       Date:  2013-09-25       Impact factor: 2.877

6.  dCREB2-mediated enhancement of memory formation.

Authors:  Thomas C Tubon; Jiabin Zhang; Eugenia L Friedman; Haining Jin; Erin D Gonzales; Hong Zhou; Diana Drier; Jason R Gerstner; Emily A Paulson; Robin Fropf; Jerry C P Yin
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

7.  Cyclin-dependent kinase 1-dependent phosphorylation of cAMP response element-binding protein decreases chromatin occupancy.

Authors:  Anthony T Trinh; Sang Hwa Kim; Hae-yoon Chang; Adam S Mastrocola; Randal S Tibbetts
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

8.  CREB regulation of BK channel gene expression underlies rapid drug tolerance.

Authors:  Y Wang; A Ghezzi; J C P Yin; N S Atkinson
Journal:  Genes Brain Behav       Date:  2009-02-09       Impact factor: 3.449

9.  In vivo circadian oscillation of dCREB2 and NF-κB activity in the Drosophila nervous system.

Authors:  Anne K Tanenhaus; Jiabin Zhang; Jerry C P Yin
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Drug-induced epigenetic changes produce drug tolerance.

Authors:  Yan Wang; Harish R Krishnan; Alfredo Ghezzi; Jerry C P Yin; Nigel S Atkinson
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.